Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-25T08:40:52.177Z Has data issue: false hasContentIssue false

Impact of clinical guidance and rapid molecular pathogen detection on evaluation and outcomes of febrile or hypothermic infants

Published online by Cambridge University Press:  03 September 2020

Jennifer Crook
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Meng Xu
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
James C. Slaughter
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Jeremy Willis
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Whitney Browning
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Cristina Estrada
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
James Gay
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Gale Thomas
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Alison Benton
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Criziel Quinn
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Jonathan Schmitz
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
Ritu Banerjee*
Affiliation:
Vanderbilt University Medical Center, Nashville, TN
*
Author for correspondence: Ritu Banerjee, E-mail: [email protected]

Abstract

Objective:

To quantify the impact of clinical guidance and rapid respiratory and meningitis/encephalitis multiplex polymerase chain reaction (mPCR) testing on the management of infants.

Design:

Before-and-after intervention study.

Setting:

Tertiary-care children’s hospital.

Patients:

Infants ≤90 days old presenting with fever or hypothermia to the emergency department (ED).

Methods:

The study spanned 3 periods: period 1, January 1, 2011, through December 31, 2014; period 2, January 1, 2015, through April 30, 2018; and period 3, May 1, 2018, through June 15, 2019. During period 1, no standardized clinical guideline had been established and no rapid pathogen testing was available. During period 2, a clinical guideline was implemented, but no rapid testing was available. During period 3, a guideline was in effect, plus mPCR testing using the BioFire FilmArray respiratory panel 2 (RP 2) and the meningitis encephalitis panel (MEP). Outcomes included antimicrobial and ancillary test utilization, length of stay (LOS), admission rate, 30-day mortality. Outcomes were compared across periods using Kruskal-Wallis and Pearson tests and interrupted time series analysis.

Results:

Overall 5,317 patients were included: 2,514 in period 1, 2,082 in period 2, and 721 in period 3. Over the entire study period, we detected reductions in the use of chest radiographs, lumbar punctures, LOS, and median antibiotic duration. After adjusting for temporal trends, we observed that the introduction of the guideline was associated with reductions in ancillary tests and lumbar punctures. Use of mPCR testing with the febrile infant clinical guideline was associated with additional reductions in ancillary testing for all patients and a higher proportion of infants 29–60 days old being managed without antibiotics.

Conclusions:

Use of mPCR testing plus a guideline for young infant evaluation in the emergency department was associated with less antimicrobial and ancillary test utilization compared to the use of a guideline alone.

Type
Original Article
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Caliendo, A. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis 2011;52 suppl 4:S326S330.10.1093/cid/cir047CrossRefGoogle ScholarPubMed
Byington, CL, Enriquez, FR, Hoff, C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004;113:16621666.10.1542/peds.113.6.1662CrossRefGoogle ScholarPubMed
Piralla, A, Lunghi, G, Percivalle, E, et al. FilmArray respiratory panel performance in respiratory samples from neonatal care units. Diagn Microbiol Infect Dis 2014;79:183186.10.1016/j.diagmicrobio.2014.02.010CrossRefGoogle ScholarPubMed
Wabe, N, Li, L, Lindeman, R, et al. Impact of rapid molecular diagnostic testing of respiratory viruses on outcomes of adults hospitalized with respiratory illness: a multicenter quasi-experimental study. J Clin Microbiol 2019;57.Google ScholarPubMed
Xu, M, Qin, X, Astion, M, et al. Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol 2013;139:118123.10.1309/AJCPH7X3NLYZPHBWCrossRefGoogle Scholar
Rappo, U, Schuetz, AN, Jenkins, SG, et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol 2016;54:20962103.10.1128/JCM.00549-16CrossRefGoogle ScholarPubMed
Brendish, NJ, Malachira, AK, Armstrong, L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017;5:401411.10.1016/S2213-2600(17)30120-0CrossRefGoogle ScholarPubMed
Doan, Q, Enarson, P, Kissoon, N, Klassen, TP, Johnson, DW. Rapid viral diagnosis for acute febrile respiratory illness in children in the emergency department. Cochrane Database Syst Revs 2014:Cd006452.10.1002/14651858.CD006452.pub4CrossRefGoogle ScholarPubMed
McCulloh, RJ, Andrea, S, Reinert, S, Chapin, K. Potential utility of multiplex amplification respiratory viral panel testing in the management of acute respiratory infection in children: a retrospective analysis. J Pediatr Infect Dis Soc 2014;3:146153.10.1093/jpids/pit073CrossRefGoogle ScholarPubMed
Nelson, R, Stockmann, C, Hersh, A, et al. Economic analysis of rapid and sensitive polymerase chain reaction testing for influenza infections in children. Pediatr Infect Dis J 2015;34:577582.10.1097/INF.0000000000000703CrossRefGoogle ScholarPubMed
Subramony, A, Zachariah, P, Krones, A, Whittier, S, Saiman, L. Impact of multiplex polymerase chain reaction testing for respiratory pathogens on healthcare resource utilization for pediatric inpatients. J Pediatr 2016;173:196201.10.1016/j.jpeds.2016.02.050CrossRefGoogle ScholarPubMed
Caviness, AC, Demmler, GJ, Almendarez, Y, Selwyn, BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008;153:164169.10.1016/j.jpeds.2008.02.031CrossRefGoogle ScholarPubMed
DePorre, AG, Aronson, PL, McCulloh, RJ. Facing the ongoing challenge of the febrile young infant. Crit Care (London) 2017;21:68.10.1186/s13054-017-1646-9CrossRefGoogle ScholarPubMed
Ramers, C, Billman, G, Hartin, M, Ho, S, Sawyer, MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000;283:26802685.10.1001/jama.283.20.2680CrossRefGoogle ScholarPubMed
Sharp, J, Harrison, CJ, Puckett, K, et al. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J 2013;32:213216.Google ScholarPubMed
Aronson, PL, Thurm, C, Alpern, ER, et al. Variation in care of the febrile young infant <90 days in US pediatric emergency departments. Pediatrics 2014;134:667677.10.1542/peds.2014-1382CrossRefGoogle ScholarPubMed
Woll, C, Neuman, MI, Aronson, PL. Management of the Febrile Young Infant: update for the 21st century. Pediatr Emergency Care 2017;33:748753.10.1097/PEC.0000000000001303CrossRefGoogle ScholarPubMed
Blaschke, AJ, Korgenski, EK, Wilkes, J, et al. Rhinovirus in febrile infants and risk of bacterial infection. Pediatrics 2018;141.Google ScholarPubMed
Mahajan, P, Browne, LR, Levine, DA, et al. Risk of bacterial coinfections in febrile infants 60 days old and younger with documented viral infections. J Pediatr 2018;203:86–91.e82.10.1016/j.jpeds.2018.07.073CrossRefGoogle ScholarPubMed
Titus, MO, Wright, SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003;112:282284.10.1542/peds.112.2.282CrossRefGoogle ScholarPubMed
Eichinger, A, Hagen, A, Meyer-Buhn, M, Huebner, J. Clinical benefits of introducing real-time multiplex PCR for cerebrospinal fluid as routine diagnostic at a tertiary-care pediatric center. Infection 2019;47:5158.10.1007/s15010-018-1212-7CrossRefGoogle Scholar
McFall, C, Salimnia, H, Lephart, P, Thomas, R, McGrath, E. Impact of early multiplex filmarray respiratory pathogen panel (RPP) assay on hospital length of stay in pediatric patients younger than 3 months admitted for fever or sepsis workup. Clin Pediatr 2018;57:12241226.10.1177/0009922817740667CrossRefGoogle ScholarPubMed
Burstein, B, Dubrovsky, AS, Greene, AW, Quach, C. National survey on the impact of viral testing for the ED and inpatient management of febrile young infants. Hosp Pediatr 2016;6:226233.10.1542/hpeds.2015-0195CrossRefGoogle ScholarPubMed
Aghaali, M, Hashemi-Nazari, SS. Association between early antibiotic exposure and risk of childhood weight gain and obesity: a systematic review and meta-analysis. J Pediatr Endocrinol Metab 2019;32:439445.10.1515/jpem-2018-0437CrossRefGoogle ScholarPubMed
Ahmadizar, F, Vijverberg, SJH, Arets, HGM, et al. Early life antibiotic use and the risk of asthma and asthma exacerbations in children. Pediatr Allergy Immunol 2017;28:430437.CrossRefGoogle ScholarPubMed
Baker, MD, Bell, LM, Avner, JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med 1993;329:14371441.10.1056/NEJM199311113292001CrossRefGoogle ScholarPubMed
Baskin, MN, O’Rourke, EJ, Fleisher, GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992;120:2227.CrossRefGoogle ScholarPubMed
Biondi, EA, Byington, CL. Evaluation and management of febrile, well-appearing young infants. Infect Dis Clin N Am 2015;29:575585.10.1016/j.idc.2015.05.008CrossRefGoogle ScholarPubMed
Byington, CL, Reynolds, CC, Korgenski, K, et al. Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics 2012;130:e16e24.10.1542/peds.2012-0127CrossRefGoogle ScholarPubMed
Gomez, B, Mintegi, S, Bressan, S, Da Dalt, L, Gervaix, A, Lacroix, L. Validation of the “step-by-step” approach in the management of young febrile infants. Pediatrics 2016;138.Google ScholarPubMed
Huppler, AR, Eickhoff, JC, Wald, ER. Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature. Pediatrics 2010;125:228233.10.1542/peds.2009-1070CrossRefGoogle ScholarPubMed
Jaskiewicz, JA, McCarthy, CA, Richardson, AC, et al. Febrile infants at low risk for serious bacterial infection—an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994;94:390396.Google ScholarPubMed
Aronson, PL, Shabanova, V, Shapiro, ED, et al. A prediction model to identify febrile infants ≤60 days at low risk of invasive bacterial infection. Pediatrics 2019;144.Google ScholarPubMed
Kuppermann, N, Dayan, PS, Levine, DA, et al. A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr 2019;173:342351.10.1001/jamapediatrics.2018.5501CrossRefGoogle ScholarPubMed
Supplementary material: File

Crook et al. supplementary material

Crook et al. supplementary material

Download Crook et al. supplementary material(File)
File 1 MB